+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years - 65Years
All Genders
ID07874620

Randomized Study of Cebranopadol to Reduce Opioid Withdrawal Symptoms in Adults with Chronic Pain

Led by Adneuris Therapeutics, Inc. · Updated on 2026-10-23

45

Participants Needed

2

Research Sites

13 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating cebranopadol, a drug, to see if multiple doses can reduce opioid withdrawal signs and symptoms in adults with chronic pain who are physically dependent on prescribed opioids. This Phase 2 trial compares two different dosing schedules of cebranopadol with a placebo. The study also examines pain levels, safety, tolerability, and how the drug is processed by the body. Participants will first complete outpatient screening, then be admitted as inpatients for treatment. Their current opioid will be stopped after the morning dose on Day -1 to confirm withdrawal symptoms using specific scales. Those who meet withdrawal criteria will resume opioids briefly before being randomly assigned to one of two cebranopadol dosing regimens or placebo. The study drug is given orally every 12 hours for 48 hours during inpatient stay. Rescue medication is available if needed, and participants resume their prescribed opioids at least 12 hours after the last study dose. During the inpatient treatment, participants undergo assessments for withdrawal, pain, safety, and drug levels. After treatment, they stay monitored until discharge on Day 4. A safety follow-up call is conducted around Day 7. Researchers measure withdrawal severity using the Clinical Opiate Withdrawal Scale over 48 hours as the main outcome, along with other measures of pain, medication use, and safety. The total participation lasts about one week.

CONDITIONS

Brief Title

A Study of Cebranopadol for Opioid Withdrawal Symptoms in Adults With Chronic Pain

Research Team

S

Study Director Adneuris Therapeutics

C

Clinical Development Adneuris Therapeutics

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here